dr. oh on validating a whole-blood rna prognostic signature in mcrpc
Published 10 years ago • 70 plays • Length 1:11Download video MP4
Download video MP3
Similar videos
-
1:22
dr. oh on validating gene signatures in mcrpc
-
1:17
dr. oh on a biomarker development trial in mcrpc
-
1:29
dr. oh on recognizing symptom burden in advanced prostate cancer
-
1:24
a cg ctdna-based prognostic model for predicting os in mcrpc treated with potent ar inhibition
-
3:33
prophecy trial: ar-v7 ctcs as a biomarker in mcrpc
-
1:56
dr. oh on targeted treatment in metastatic castration-resistant prostate cancer
-
1:32
dr. william oh on prostate cancer monitoring
-
8:53
prognostic biomarkers to guide treatment of mcrpc
-
1:36
dr. oh on results of chemotherapy versus arta in prostate cancer
-
0:54
convincing long-term survival with abiraterone in mcrpc
-
1:15
dr. oh on the hormone-sensitive setting in prostate cancer
-
1:02
dr. gafita on prognostic models for treatment with 177lu-psma-617 in mcrpc
-
1:05
dr. sehdev, medical oncologist: what is mcrpc and what is the prognosis?
-
1:46
dr. agarwal on the qol with apalutamide in metastatic castration-sensitive prostate cancer
-
4:54
molecular and clinical characterization of mcrpc patients achieving deep psa responses to bat
-
2:48
assessing parp inhibition and brca1/2 as a prognostic biomarker in mcrpc
-
1:15
magnitude: hrqol in patients with mcrpc receiving niraparib and abiraterone
-
5:18
metastatic castration-resistant prostate cancer by fellows from uci
-
1:37
dr. daniel george on the incorporation of radium-223 in advanced prostate cancer